Pharmacy API

News and Press

Truepill turns to in-home lab testing with $75M in new funding

MedCity News • Sept. 9, 2020

Truepill, the startup behind direct-to-consumer health brands like Hims and Nurx, plans to expand into lab testing. The startup raised $75 million in a series C funding round.

Digital Pharmacy Truepill Raises $25 Million To Expand Telehealth Offerings As Revenue Could Reach $200 Million This Year

Forbes • July 8, 2020

Today, the company said that it had raised $25 million from Optum Ventures (the venture fund of Optum Health), Initialized Capital, TI Platform Fund, Sound Ventures and others, bringing Truepill’s total funding to $39 million at a valuation that Forbes estimates at nearly $300 million.